Globally renowned contract development and manufacturing organisation (CDMO) Piramal Pharma Solutions (PPS) will showcase its expertise at the upcoming CPHI Milan. As biopharma supply chains grow more complicated and expensive, PPS covers everything from early-stage development through to commercial manufacturing.
Services provided by PPS include a wide range of pharmaceutical modalities and manufacturing services, including small molecules, biologics, antibody-drug conjugates, highly potent active pharmaceutical ingredients, sterile fill/finish, peptide manufacturing, clinical trial supplies and commercial drug product manufacturing.
The company’s global network of development and manufacturing facilities supports pharmaceutical and biotechnology companies throughout the product lifecycle.
What visitors can expect at CPHI Milan
CPHI Milan is set to bring together the global pharmaceutical industry when it returns to Fiera Milano from 6-8 October 2026.
At the event, visitors will have the opportunity to meet the PPS team to discuss development and manufacturing challenges, explore integrated contract development and manufacturing organisation services, and learn how PPS supports complex pharmaceutical programmes from discovery to commercial supply.
Furthermore, PPS will be showcasing the expansion of its sterile fill/finish site in Lexington, Kentucky, US. The $85m upgrade extends the capabilities of the facility, adding commercial-scale manufacturing, and a new microbiology lab, as well as extensive infrastructure upgrades.
Recognised as one of the sector’s largest international events, CPHI connects pharmaceutical manufacturers, contract development and manufacturing organisations, biotech companies, suppliers, regulators and technology providers from across the drug development and manufacturing value chain.
With a history spanning more than three decades, CPHI has grown from a European exhibition into a global meeting place for the pharmaceutical industry. Today, it attracts exhibitors and visitors from more than 160 countries, creating opportunities to explore new technologies, build partnerships and discuss the trends shaping the future of healthcare.
The three-day event combines a large international exhibition with an extensive conference programme, giving attendees access to industry leaders, technical experts and decision-makers from every stage of the pharmaceutical lifecycle.
This year’s event introduces new features focused on some of the industry’s fastest-moving priorities, including AI and digital technologies, cold chain logistics, contamination control and pharmaceutical labelling. Alongside the exhibition floor, conference sessions will explore topics such as biomanufacturing, regulatory change, sustainability, supply chain resilience and advances in drug development.
Whether attendees are looking for manufacturing expertise, new technologies or strategic partnerships, CPHI Milan offers a single destination to engage with the companies driving innovation across the pharmaceutical sector.
Visit Piramal Pharma Solutions at stand 10F57 during CPHI Milan 2026 to meet the team and explore its integrated drug development and manufacturing capabilities across the pharmaceutical value chain.
